New risk factors and vascular disease markers, such as hyperfibrinogenemia (HF), participate in platelet aggregation, modulate endothelial function, promote the proliferation of smooth muscle, and express the inflammatory component in atherogenesis [2–4], mediated by TNF-α which reflects the endothelial activation level. This evidence concerns the gene TNF and hydrops fetalis.